Journos News - Breaking News, World News, Top Stories, Todays Headlines and Flash Reports
Tuesday, July 14, 2026
  • Login
  • Home
  • World
    • Africa
    • Americas
    • Asia
    • Europe
    • Middle East
    • Oceania
  • Politics
  • Business
  • Technology
  • Health
  • Science
  • Sports
  • Entertainment
  • Culture
No Result
View All Result
  • Home
  • World
    • Africa
    • Americas
    • Asia
    • Europe
    • Middle East
    • Oceania
  • Politics
  • Business
  • Technology
  • Health
  • Science
  • Sports
  • Entertainment
  • Culture
No Result
View All Result
Journos News - Breaking News, World News, Top Stories, Todays Headlines and Flash Reports
No Result
View All Result
Home Health General Health Coverage

FDA Says Popular Cold Medicine Doesn’t Work – Here’s What to Use Instead

Major Cold Medicine Change: FDA Moves to Ban Ineffective Decongestant

The Daily Desk by The Daily Desk
June 15, 2026
in General Health Coverage, Health
0
FDA Declares Leading Decongestant Useless – What You Need to Know - Jonathan Poet/AP Photo

FDA to Ban Ineffective Decongestant – How It Affects Cold & Allergy Medicine - Jonathan Poet/AP Photo

FDA Declares Popular Decongestant Ineffective – What Now?

📢 Big Changes Coming to Cold & Cough Medicines
🏥 FDA Moves to Ban Phenylephrine in Pills & Syrups
💊 Consumers Must Turn to More Effective Alternatives

Popular Cold Medicine Ingredient Doesn’t Work, FDA Says

Big changes are coming to your local pharmacy’s cold and cough aisle. The Food and Drug Administration (FDA) has announced plans to phase out phenylephrine, a leading decongestant found in hundreds of over-the-counter (OTC) medications, including Sudafed PE, DayQuil, and NyQuil.

The reason? It doesn’t actually relieve nasal congestion.

Despite being a common ingredient in cold and allergy medications, experts have questioned phenylephrine’s effectiveness for years. Now, the FDA has formally proposed revoking its use in oral pills and liquid solutions, meaning drugmakers will soon have to remove or reformulate their products.

Why Is the FDA Taking Action Now?

The decision comes after federal health advisers voted unanimously last year that phenylephrine does not work when taken orally.

RELATED POSTS

Why Scratching Bug Bites Makes Them Worse, According to New Research

WHO Launches Clinical Trial of Two Ebola Treatments as Congo’s Bundibugyo Outbreak Grows

New Jersey Targets Employers With New Medicaid Fee as Other States Consider Similar Policies

Medicaid Work Requirement Guidance Raises Concerns for Patients With Chronic Illnesses

Extreme Weather Anxiety on the Rise as Experts Urge Preparedness and Support

Genomic Test Could Help Millions of Breast Cancer Patients Avoid Chemotherapy

Key Findings from FDA Experts:
Large, recent studies found phenylephrine was no better than a placebo at clearing nasal congestion.
Older studies from the 1960s and 1970s that initially supported the drug’s approval were found to be flawed and unreliable.
The $1.8 billion market for oral phenylephrine products could soon disappear.

Important Note: This decision only applies to oral phenylephrine (pills & syrups). Phenylephrine-based nasal sprays will remain available, as they are still considered effective.

What Are the Best Alternatives for Nasal Congestion?

With oral phenylephrine on the way out, what should you use instead?

Pseudoephedrine (Behind-the-Counter)

If you still prefer pills or syrups, you’ll need to ask for medications containing pseudoephedrine (the original decongestant in Sudafed).

Available behind the pharmacy counter (no prescription needed)
Found in Sudafed, Claritin-D, Allegra-D
More effective than phenylephrine

You must show a photo ID to purchase, due to laws preventing its misuse in methamphetamine production.

Nasal Sprays for Fast Relief

  • Saline sprays & rinses (e.g., Neti pots) – Quickly clear mucus buildup.
  • Nasal steroids (Flonase, Nasacort, Rhinocort) – Best for long-term congestion relief, but must be used daily for full effect.
  • Antihistamine sprays (Astepro) – Act faster than steroids for short-term relief.

Why Doesn’t Oral Phenylephrine Work?

According to University of Florida researchers, phenylephrine is quickly broken down in the stomach, making it ineffective before it even reaches the bloodstream.

Dr. Leslie Hendeles, a leading researcher on phenylephrine, explains:
“This is a good drug, but not when it’s swallowed. It gets inactivated in the gut, so it can’t get to the nose.”

Even at doses 400% higher than currently recommended, phenylephrine still failed to relieve congestion. Increasing the dose even more could lead to dangerously high blood pressure, which is why the FDA ruled out stronger doses as an option.

What Happens Next?

The process to remove oral phenylephrine from store shelves won’t happen overnight.

Next Steps in the FDA Process:
6-month public comment period – Consumers & companies can submit feedback.
FDA review & final decision – Could take over a year for drugmakers to reformulate or remove products.
Possible delays – Drug companies may request additional hearings, slowing the process further.

Drugmakers Pushing Back

The Consumer Healthcare Products Association, which represents drug manufacturers, wants to keep phenylephrine available, arguing that consumers should have the right to choose their medications.

However, researchers like Dr. Randy Hatton (who co-led the FDA petition) disagree:
“Choosing from something that doesn’t work isn’t really a choice.”

What Should Consumers Do Now?

Avoid OTC pills labeled ‘PE’ – They won’t help your congestion.
Ask for pseudoephedrine at the pharmacy counter – It’s still available and works better.
Use nasal sprays & saline rinses – These provide fast and effective relief.
Consult your doctor or pharmacist – They can recommend the best alternative for your symptoms.

With the FDA cracking down on ineffective medications, consumers will soon have better options to actually relieve congestion. Stay informed and choose medications that truly work!

Source

Tags: #AllergyRelief#ColdAndFlu#ColdMedicine#ColdRemedies#ConsumerHealth#DayQuil#Decongestant#DrugSafety#FDA#FDABan#FDAUpdate#Flonase#FluRemedies#FluSeason#HealthAlert#HealthCare#HealthNews#HealthTips#MedicalNews#MedicineUpdate#NasalCongestion#NasalSpray#OverTheCounter#PharmacyNews#Phenylephrine#Pseudoephedrine#SinusRelief#StayHealthy#Sudafed#WellnessTips
The Daily Desk

The Daily Desk

The Daily Desk is a contributor at JournosNews.com covering politics, media, governance, and the evolving dynamics of public discourse. Stories published under this byline are produced in accordance with JournosNews' editorial standards, with an emphasis on verified reporting, accuracy, context, and impartiality.

Related Posts

Why Scratching Bug Bites Makes Them Worse, According to New Research

by The Daily Desk
July 3, 2026
0
Person scratching a mosquito bite on their arm outdoors - AP Photo/Rick Bowmer, File

WASHINGTON - Many people instinctively scratch a mosquito bite, poison ivy rash, or other itchy skin irritation for immediate relief....

Read moreDetails

WHO Launches Clinical Trial of Two Ebola Treatments as Congo’s Bundibugyo Outbreak Grows

by The Daily Desk
July 3, 2026
0
Healthcare workers at an Ebola treatment center during Congo clinical trial - AP Photo/Moses Sawasawa, File

The World Health Organization (WHO) has launched a clinical trial in the Democratic Republic of Congo to evaluate two potential...

Read moreDetails

New Jersey Targets Employers With New Medicaid Fee as Other States Consider Similar Policies

by The Daily Desk
July 2, 2026
0
New Jersey State House as lawmakers approve Medicaid employer fee policy - AP Photo/Seth Wenig, File

New Jersey has become the latest state to require certain employers to help offset Medicaid costs by introducing a new...

Read moreDetails

Medicaid Work Requirement Guidance Raises Concerns for Patients With Chronic Illnesses

by The Daily Desk
June 15, 2026
0
Patient reviewing Medicaid coverage requirements after federal policy changes - AP Photo/Rebecca, Blackwell, File

NEW YORK - Patients living with serious health conditions and disabilities may face new challenges proving they qualify for exemptions...

Read moreDetails

Extreme Weather Anxiety on the Rise as Experts Urge Preparedness and Support

by The Daily Desk
June 15, 2026
0
Residents facing severe weather prepare emergency plans to reduce stress - AP Photo/Gerald Herbert

As hurricanes, wildfires, floods, tornadoes and other extreme weather events become increasingly common, mental health experts are drawing attention to...

Read moreDetails

Genomic Test Could Help Millions of Breast Cancer Patients Avoid Chemotherapy

by The Daily Desk
June 15, 2026
0
Researcher reviewing breast cancer genomic testing results in laboratory - Credit: Getty Images

Millions of people with hormone-sensitive breast cancer may be able to avoid chemotherapy without reducing their chances of remaining cancer-free,...

Read moreDetails

Why Brain Freeze Continues to Fascinate Scientists Beyond the Ice Cream Cone

by The Daily Desk
June 15, 2026
0
Person experiencing brain freeze after eating ice cream quickly - Credit: Getty Images

Why Brain Freeze May Reveal More About the Brain Than Ice Cream Scientists say the common cold-triggered headache offers clues...

Read moreDetails

France Permits Healthy Cruise Passengers to Disembark After Gastrointestinal Illness Outbreak

by The Daily Desk
May 15, 2026
0
Cruise ship passengers disembarking after gastroenteritis outbreak in France - AP Photo/Caroline Blumberg

French authorities allowed asymptomatic passengers to leave a cruise ship near Bordeaux after a gastrointestinal illness outbreak sickened hundreds aboard...

Read moreDetails

Global Health Coordination Intensifies After U.S. Passenger Tests Positive for Hantavirus

by The Daily Desk
June 15, 2026
0
Passengers evacuated from MV Hondius during hantavirus containment operation - AP Photo

A U.S. passenger evacuated from the Dutch-operated cruise ship MV Hondius after a hantavirus outbreak has tested mildly positive for...

Read moreDetails
Load More
Next Post
Elephants Trumpet with Joy After 40km Journey to a Bigger Home - Jo Howell/Zoos Victoria via AP Photo

Nine Elephants Relocated to a Spacious Zoo – See Their Reaction!

Will Europe Build Its Own Army? Zelenskyy Says the Time Is Now - Matthias Shrader/AP Photo

Zelenskyy Calls for a European Army as U.S. Shifts Ukraine Policy

Will Russia Make Concessions? U.S. Officials Set to Begin Talks - AFP/Getty Images/Reuters/AP/CNN

Trump Officials to Meet Russian Leaders for Ukraine Peace Talks

JournosNews logo

Journos News delivers globally neutral, fact-based journalism that meets international media standards — clear, credible, and made for a connected world.

  • Categories
  • World News
  • Politics
  • Business & Markets
  • Technology
  • Health
  • Science
  • Sports
  • Arts & Culture
  • Resources
  • Editorial Standards
  • Submit a Story
  • Advertise with Us
  • Syndication & Partnerships
  • Site Map
  • Press & Media Kit
  • Editorial Team
  • Careers

Join thousands of readers receiving the latest updates, tips, and exclusive insights straight to their inbox. Never miss an important story again.

  • About Us
  • Editorial & Trust Center
  • Contact Us
  • Privacy Policy
  • Terms of Use & Copyright Notice

© JournosNews.com All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
JournosNews

Independent Journalism.
Verified Facts.

You're about to read a professionally edited article from JournosNews.com.

Every article is produced in accordance with our editorial standards, emphasizing factual accuracy, transparent attribution, fairness, editorial independence, and meaningful context.

Editorial Standards
No Result
View All Result
  • Home
  • World
    • Africa
    • Americas
    • Asia
    • Europe
    • Middle East
    • Oceania
  • Politics
  • Business
  • Technology
  • Health
  • Science
  • Sports
  • Entertainment
  • Culture

© JournosNews.com All rights reserved.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.